Übersetzung Und Validierung Einer Deutschen Version Der Intensive Care Unit Mobility Scale (IMS) Translation and Validation of the Intensive Care Unit Mobility Scale (IMS)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Predictive validity of the IMS
Study Overview
Brief Summary
Intensive care unit acquired weakness (ICUAW) is a common issue in critically ill patients. Early mobilization can reduce the occurrence of ICUAW. This requires a standardized procedure based on validated scales. One such scale is Carol Hodgson's ICU Mobility Scale (IMS).
The subject of the study is the translation of the IMS into German and the validation of its reliability and predictive power with regard to various clinical outcomes. Furthermore we want to investigate the communication about the mobilisation status of ICU-patients between the different medical disciplines that are involved in patient care.
Study Design
- Study Type
- Observational
- Observational Model
- Other
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Critically ill adults (age: ≥ 18 years)
- •Expected length of stay in ICU > 24h
- •Ventilation support
Exclusion Criteria
- •Patients transferred from other ICUs
- •Patients with pre-existing functional limitations
- •Patients with functional limitations due to the admission diagnosis (e.g. stroke. with hemiparesis)
Outcomes
Primary Outcomes
Predictive validity of the IMS
Time Frame: approximate 28 days (till ICU discharge)
Predictive validity of the IMS-score performed in the first 24 hours after admission to the ICU for the length of stay in the ICU
Secondary Outcomes
- Discharge location(approximate at 28 days (at hospital discharge))
- Duration of mechanical ventilation(approximate 28 days (till ICU discharge))
- MRC Score(approximate 28 days (till ICU discharge))
- Hospital LOS(approximate 28 days (till discharge))
- ICU mortality(approximate 28 days (till ICU discharge))
- Muscle strength(approximate 28 days (till ICU discharge))
- IMS during the ICU stay(approximate 28 days (till ICU discharge))
- in-hospital mortality(approximate 28 days (till discharge))
- 90-day mortality(at 90 days)
- 90-day function(at 90 days)
- ICU-LOS(approximate 28 days (till ICU discharge))
Investigators
Stefan J Schaller
Deputy Clinical Director
Charite University, Berlin, Germany